Among 53 genes affected by these mutations, 23 exhibited no alteration in any immunotherapy tumor, suggesting that cells with mutations in these genes might be eliminated by T cells after blockade of PD-1/PD-L1 checkpoint. Here, CD274 is linked to neoplasm.